Latest posts

May 4, 2016

Guinness Record Set With 25 Continuous Hours in Virtual Reality

Posted by in category: virtual reality

The Guinness Book of World records, a record of the extraordinary (and often insane) stunts people will pull for notoriety, and now the book has its first virtual reality entry. Watch as Derek Westerman swaps reality for Tilt Brush inside the HTC Vive and stays there for 25 hours straight.

It’s a desire within most of us, to do something extraordinary in life. Most of us are content to achieve this by parent children, going bungee jumping or backpacking around Europe. But there are a group of people for whom only documented proof of their unique abilities or achievements is enough – they’re the record breakers, as documented since 1955 by the world famous Guinness World Records.

Continue reading “Guinness Record Set With 25 Continuous Hours in Virtual Reality” »

May 4, 2016

The surprising way Transhumanist Zoltan Istvan could make it to the White House

Posted by in categories: life extension, transhumanism

Interesting article by CNET, the leading tech site in traffic, on how a strong science, longevity, and technology platform could end up in Washington in 2016:

CNET exclusive: The only pro-immortality candidate could eventually team up with one of the big names in the race.

May 4, 2016

Rich and powerful warn robots are coming for your jobs

Posted by in categories: employment, robotics/AI

LOS ANGELES Some of the richest, smartest and most powerful humans have an important message for the rest of us as they convened this week to discuss pressing global issues: the robots are coming.

At the Milken Institute’s Global Conference in Beverly Hills, California, at least four panels so far have focused on technology taking over markets to mining — and most importantly, jobs.

“Most of the benefits we see from automation is about higher quality and fewer errors, but in many cases it does reduce labor,” Michael Chui, a partner at the McKinsey Global Institute, said on Tuesday during a panel on “Is Any Job Truly Safe?”

May 4, 2016

Fresh emergency organs may soon be delivered by medical drones

Posted by in categories: biotech/medical, drones

Lung Biotechnology, a biotech firm, commissioned 1,000 medical drones that’ll deliver transplant organs to a network of hospitals pending FAA and FDA approval.

May 4, 2016

Walking with Gear VR

Posted by in categories: habitats, virtual reality

Walk around a virtual apartment or an art gallery with the Gear VR.

Demo by Interactive Lab.

May 4, 2016

Virtual reality painting

Posted by in category: virtual reality

Virtual reality painting is here.

May 4, 2016

Airbus Defence and Space signs contract to build Biomass – the European Space Agency’s forest mission

Posted by in categories: geopolitics, space travel, treaties

1st P-band radar in space will measure the amount of biomass and carbon locked in the world’s forests and how this changes over time — Biomass satellite will provide support to United Nations treaties, notably the Reduction of Emissions due to Deforestation and Forest Degradation

Airbus Defence and Space, the world’s second largest space company has signed a contract with the European Space Agency (ESA) to build its next Earth Explorer mission, the Biomass satellite. Biomass is due to launch in 2021 and will measure forest biomass to assess terrestrial carbon stocks and fluxes for five years.

The spacecraft will carry the first space-borne P-band synthetic aperture radar to deliver exceptionally accurate maps of tropical, temperate and boreal forest biomass that are not obtainable by ground measurement techniques. The mission will collect frequent information on global forests to determine the distribution of above-ground biomass in these forests and measure annual changes. The 5-year mission will see at least eight growth cycles in the worlds’ forests.

Continue reading “Airbus Defence and Space signs contract to build Biomass – the European Space Agency’s forest mission” »

May 4, 2016

Preparing for the Future of Artificial Intelligence

Posted by in categories: biotech/medical, computing, health, robotics/AI

Today, we’re announcing a new series of workshops and an interagency working group to learn more about the benefits and risks of artificial intelligence.

There is a lot of excitement about artificial intelligence (AI) and how to create computers capable of intelligent behavior. After years of steady but slow progress on making computers “smarter” at everyday tasks, a series of breakthroughs in the research community and industry have recently spurred momentum and investment in the development of this field.

Today’s AI is confined to narrow, specific tasks, and isn’t anything like the general, adaptable intelligence that humans exhibit. Despite this, AI’s influence on the world is growing. The rate of progress we have seen will have broad implications for fields ranging from healthcare to image- and voice-recognition. In healthcare, the President’s Precision Medicine Initiative and the Cancer Moonshot will rely on AI to find patterns in medical data and, ultimately, to help doctors diagnose diseases and suggest treatments to improve patient care and health outcomes.

Continue reading “Preparing for the Future of Artificial Intelligence” »

May 4, 2016

Faster, cheaper way to produce new antibiotics

Posted by in category: biotech/medical


A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol. By expressing the genes involved in the production of pleuromutilin in a different type of fungus, the researchers were able to increase production by more than 2,000 per cent.

With resistance growing to existing antibiotics, there is a vital and urgent need for the discovery and development of new antibiotics that are cost effective. Promising developments are derivatives of the antibiotic pleuromutilin, which are isolated from the mushroom Clitopilus passeckerianus.

These new compounds are some of the only new class of antibiotics to join the market recently as human therapeutics. Furthermore, with their novel mode of action and lack of cross-resistance, pleuromutilins and their derivatives represent a class with further great potential, particularly for treating resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and extensively drug resistant tuberculosis (XTB).

May 4, 2016

Biogen haemophilia spin-out to develop gene therapies and long-acting factors

Posted by in categories: business, life extension

The new entity will focus on a haemophilia pipeline utilising the XTEN half-life extension technology, bispecific antibodies and gene therapies.

Biogen announced yesterday it is planning to spin-out its haemophilia business into an independent, public firm based in Boston, Massachusetts by early next year.

Management said during a conference call this was the right time for a spin-out as Biogen’s haemophilia business has matured.

Continue reading “Biogen haemophilia spin-out to develop gene therapies and long-acting factors” »

Page 6 of 800First345678910Last